Antioxidant quantum dots for spinal cord injuries: A review on advancing neuroprotection and regeneration in neurological disorders
Source abstract
Abstract
Abstract Spinal cord injury (SCI) is a serious damage to the spinal cord that can lead to life-long disability. It is classified by initial trauma and subsequent neuronal degeneration, marked by permanent impairment of brain function across the whole brain. This condition results in a progressive deterioration of cognitive function in patients and is frequently associated with psychological symptoms such as body’s movement (paralysis and autonomic dysreflexia), imposing a significant burden on both patients and their families. Nanomaterials such as antioxidant quantum dots (QDs) are an innovative approach, providing dual functionality in theranostics – concurrent therapeutic and diagnostic capacities in the biomedical domain, which can be utilized for disease prevention and therapy. This review thoroughly examines the potential of QDs to transform SCI care due to their inherent antioxidant characteristics, nanoscale accuracy, and capacity to reduce damage caused by reactive oxygen species. It underscores their function in safeguarding brain tissue, augmenting the viability and development of transplanted stem cells, and facilitating axonal regeneration. Moreover, their versatile use in imaging and real-time assessment of treatment results highlights their transformational potential. This study is significant as it connects developing nanotechnology with regenerative medicine for SCI, providing a comprehensive overview of present advances, problems, and future prospects. It examines pivotal concerns such QD toxicity, biocompatibility, and regulatory challenges, while investigating methods for enhancing formulations and incorporating QDs with combination medicines. This review offers a pathway for enhancing QD applications in neuroprotection and regeneration, with the intention of fostering multidisciplinary research and expediting clinical translation, so facilitating new therapies for SCI that enhance patient outcomes and quality of life.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Carbon and Quantum Dots Applications · Quantum Dots Synthesis And Properties · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Science, Technology and Innovation, King Saud University , Riyadh , 11451 , Saudi Arabia
King Salman Center for Disability Research , Riyadh , 11614 , Saudi Arabia
Department of Chemistry, College of Science, King Saud University , Riyadh , 11451 , Saudi Arabia
Department of Pharmacology, College of Medicine, Shaqra University , Shaqra , 11961 , Saudi Arabia
References (100+)
Show source-provided references
1. Laurer H, Maier B, El Saman A, Lehnert M, Wyen H, Marzi I. Distribution of spinal and associated injuries in multiple trauma patients. Eur J Trauma Emerg Surg. 2007;33:476–81.10.1007/s00068-007-7124-3 ↗
2. Hasler RM, Exadaktylos AK, Bouamra O, Benneker LM, Clancy M, Sieber R, et al. Epidemiology and predictors of spinal injury in adult major trauma patients: European cohort study. Eur Spine J. 2011;20:2174–80.10.1007/s00586-011-1866-7 ↗
3. Yadollahi M, Karajizadeh M, Bordbar N, Ghahramani Z. Incidence and pattern of traumatic spine injury in a single level I trauma center of southern Iran. Chin J Traumatol. 2023;26:199–203.10.1016/j.cjtee.2023.01.001 ↗
4. De Morais DF, De Melo Neto JS, Spotti AR, Tognola WA. Predictors of clinical complications in patients with spinomedullary injury. Coluna/Columna. 2014;13:139–42.10.1590/S1808-18512014130200404 ↗
5. Calenoff L, Chessare JW, Rogers L, Toerge J, Rosen JS. Multiple level spinal injuries: importance of early recognition. Am J Roentgenol. 1978;130:665–9.10.2214/ajr.130.4.665 ↗
6. Anderson SD, Anderson DG, Vaccaro AR. Skeletal fracture demographics in spinal cord-injured patients. Arch Orthop Trauma Surg. 2004;124:193–6.10.1007/s00402-003-0605-x ↗
7. Taterra D, Skinningsrud B, Pękala PA, Hsieh WC, Cirocchi R, Walocha JA, et al. Artery of Adamkiewicz: a meta-analysis of anatomical characteristics. Neuroradiology. 2019;61:869–80.10.1007/s00234-019-02207-y ↗
8. Griessenauer CJ, Raborn J, Foreman P, Shoja MM, Loukas M, Tubbs RS. Venous drainage of the spine and spinal cord: a comprehensive review of its history, embryology, anatomy, physiology, and pathology. Clin Anat. 2015;28:75–87.10.1002/ca.22354 ↗
9. Furlan JC, Noonan V, Singh A, Fehlings MG. Assessment of impairment in patients with acute traumatic spinal cord injury: a systematic review of the literature. J Neurotrauma. 2011;28:1445–77.10.1089/neu.2009.1152 ↗
10. Sekhon LH, Fehlings MG. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine. 2001;26:S2–12.10.1097/00007632-200112151-00002 ↗
11. Krueger H, Noonan V, Trenaman L, Joshi P, Rivers C. The economic burden of traumatic spinal cord injury in Canada. Health Promot Chronic Dis Prev Can. 2013;33:113–22.10.24095/hpcdp.33.3.01 ↗
12. Harvey C, Wilson S, Greene C, Berkowitz M, Stripling T. New estimates of the direct costs of traumatic spinal cord injuries: results of a nationwide survey. Spinal Cord. 1992;30:834–50.10.1038/sc.1992.160 ↗
13. Munce SE, Wodchis WP, Guilcher SJ, Couris CM, Verrier M, Fung K, et al. Direct costs of adult traumatic spinal cord injury in Ontario. Spinal Cord. 2013;51:64–9.10.1038/sc.2012.81 ↗
14. Memish ZA, Jaber S, Mokdad AH, AlMazroa MA, Murray CJ, Al Rabeeah AA, et al. Burden of disease, injuries, and risk factors in the Kingdom of Saudi Arabia, 1990–2010. Prev Chronic Dis. 2014;11:E169.10.5888/pcd11.140176 ↗
15. Robert AA, Zamzami MM. Traumatic spinal cord injury in Saudi Arabia: a review of the literature. Pan Afr Med J. 2013;16:104.10.11604/pamj.2013.16.104.2902 ↗
16. Gosselin RA, Spiegel DA, Coughlin R, Zirkle LG. Injuries: the neglected burden in developing countries. Bull World Health Organ. 2009;87:246–a.10.2471/BLT.08.052290 ↗
17. Kwon BK, Tetzlaff W, Grauer JN, Beiner J, Vaccaro AR. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J. 2004;4:451–64.10.1016/j.spinee.2003.07.007 ↗
18. Esen E, Taşar F, Akhan O. Determination of the anti-inflammatory effects of methylprednisolone on the sequelae of third molar surgery. J Oral Maxillofac Surg. 1999;57:1201–6.10.1016/S0278-2391(99)90486-X ↗
19. Feinberg SM, Feinberg AR, Pruzansky J, Fisherman EW. Methylprednisolone (medrol), a potent new anti-inflammatory steroid: therapeutic results in allergic diseases. J Am Med Assoc. 1957;165:1560–2.10.1001/jama.1957.72980300006009b ↗
20. Piekarska K, Dratwa M, Radwan P, Radwan M, Bogunia-Kubik K, Nowak I. Pro- and anti-inflammatory cytokines and growth factors in patients undergoing in vitro fertilization procedure treated with prednisone. Front Immunol. 2023;14:1250488.10.3389/fimmu.2023.1250488 ↗
21. Nourian Dehkordi A, Mirahmadi Babaheydari F, Chehelgerdi M, Raeisi Dehkordi S. Skin tissue engineering: wound healing based on stem-cell-based therapeutic strategies. Stem Cell Res Ther. 2019;10:1–20.10.1186/s13287-019-1212-2 ↗
22. Hassanzadeh A, Rahman HS, Markov A, Endjun JJ, Zekiy AO, Chartrand MS, et al. Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities. Stem Cell Res Ther. 2021;12:297.10.1186/s13287-021-02378-7 ↗
23. Fernandez-Colino A, Iop L, Ferreira MSV, Mela P. Fibrosis in tissue engineering and regenerative medicine: treat or trigger? Adv Drug Deliv Rev. 2019;146:17–36.10.1016/j.addr.2019.07.007 ↗
24. Mahla RS. Stem cells applications in regenerative medicine and disease therapeutics. Int J Cell Biol. 2016;2016:6940283.10.1155/2016/6940283 ↗
25. Hejrati N, Wong R, Khazaei M, Fehlings MG. How can clinical safety and efficacy concerns in stem cell therapy for spinal cord injury be overcome? Expert Opin Biol Ther. 2023;23:883–99.10.1080/14712598.2023.2245321 ↗
26. Ganguly S, Wulff D, Phan C-M, Jones LW, Tang XS. Injectable and 3D extrusion printable hydrophilic silicone-based hydrogels for controlled ocular delivery of ophthalmic drugs. ACS Appl Bio Mater. 2024;7:6286–96.10.1021/acsabm.4c00901 ↗
27. Khodaverdi K, Bakhshi A, Mozafari M, Naghib SM. A review of chitosan-based nanocarriers as drug delivery systems for brain diseases: Critical challenges, outlooks and promises. Int J Biol Macromol. 2024;278:134962.10.1016/j.ijbiomac.2024.134962 ↗
28. Spencer AP, Torrado M, Custódio B, Silva-Reis SC, Santos SD, Leiro V, et al. Breaking barriers: bioinspired strategies for targeted neuronal delivery to the central nervous system. Pharmaceutics. 2020;12:192.10.3390/pharmaceutics12020192 ↗
29. Galindo AN, Rubio DAF, Hettiaratchi MH. Biomaterial strategies for regulating the neuroinflammatory response. Mater Adv. 2024;5:4025–54.10.1039/D3MA00736G ↗
30. Rocha LA, Silva D, Barata‐Antunes S, Cavaleiro H, Gomes ED, Silva NA, et al. Cell and tissue instructive materials for central nervous system repair. Adv Funct Mater. 2020;30:1909083.10.1002/adfm.201909083 ↗
31. Zimmermann R, Vieira Alves Y, Sperling LE, Pranke P. Nanotechnology for the treatment of spinal cord injury. Tissue Eng Part B: Rev. 2021;27:353–65.10.1089/ten.teb.2020.0188 ↗
32. Kubinová Š, Syková E. Nanotechnology for treatment of stroke and spinal cord injury. Nanomedicine. 2010;5:99–108.10.2217/nnm.09.93 ↗
33. Song YH, Agrawal NK, Griffin JM, Schmidt CE. Recent advances in nanotherapeutic strategies for spinal cord injury repair. Adv Drug Deliv Rev. 2019;148:38–59.10.1016/j.addr.2018.12.011 ↗
34. Parameswaranpillai J, Das P, Ganguly S. Quantum dots and polymer nanocomposites: synthesis, chemistry, and applications. Abingdon (Oxfordshire), United Kingdom: CRC Press; 2022.10.1201/9781003266518 ↗
35. Das P, Ganguly S, Marvi PK, Sherazee M, Tang X, Srinivasan S, et al. Carbon dots infused 3D printed cephalopod mimetic bactericidal and antioxidant hydrogel for uniaxial mechano‐fluorescent tactile sensor. Adv Mater. 2024;36:2409819.10.1002/adma.202409819 ↗
36. Ganguly S, Das P, Banerjee S, Das NC. Advancement in science and technology of carbon dot-polymer hybrid composites: a review. Funct Compos Struct. 2019;1:022001.10.1088/2631-6331/ab0c80 ↗
37. Reni M, Mazza E, Zanon S, Gatta G, Vecht CJ. Central nervous system gliomas. Crit Rev Oncol Hematol. 2017;113:213–34.10.1016/j.critrevonc.2017.03.021 ↗
38. Wainwright JV, Endo T, Cooper JB, Tominaga T, Schmidt MH. The role of 5-aminolevulinic acid in spinal tumor surgery: a review. J Neurooncol. 2019;141:575–84.10.1007/s11060-018-03080-0 ↗
39. Wu Q-L, Xu H-L, Xiong C, Lan Q-H, Fang M-L, Cai J-H, et al. c (RGDyk)-modified nanoparticles encapsulating quantum dots as a stable fluorescence probe for imaging-guided surgical resection of glioma under the auxiliary UTMD. Artif Cells Nanomed Biotechnol. 2020;48:143–58.10.1080/21691401.2019.1699821 ↗
40. Garrudo FF, Chapman CA, Hoffman PR, Udangawa RW, Silva JC, Mikael PE, et al. Polyaniline-polycaprolactone blended nanofibers for neural cell culture. Eur Polym J. 2019;117:28–37.10.1016/j.eurpolymj.2019.04.048 ↗
41. Dong J, Wang K, Sun L, Sun B, Yang M, Chen H, et al. Application of graphene quantum dots for simultaneous fluorescence imaging and tumor-targeted drug delivery. Sens Actuators B: Chem. 2018;256:616–23.10.1016/j.snb.2017.09.200 ↗
42. Zhang W, Huang Z, Pu X, Chen X, Yin G, Wang L, et al. Fabrication of doxorubicin and chlorotoxin-linked Eu-Gd2O3 nanorods with dual-model imaging and targeted therapy of brain tumor. Chin Chem Lett. 2020;31:285–91.10.1016/j.cclet.2019.04.018 ↗
43. Zhang T, Wang Y, Kong L, Xue Y, Tang M. Threshold dose of three types of quantum dots (QDs) induces oxidative stress triggers DNA damage and apoptosis in mouse fibroblast L929 cells. Int J Environ Res Public Health. 2015;12:13435–54.10.3390/ijerph121013435 ↗
44. Li J, Li K, Shao D, Ding Y, Huang L, Zheng X. The synergistic antioxidant effect of polydopamine coating with amino-functionalized graphene quantum dots on osteoblast protection against oxidative stress. Appl Surf Sci. 2023;613:155950.10.1016/j.apsusc.2022.155950 ↗
45. Ren C, Hu X, Zhou Q. Graphene oxide quantum dots reduce oxidative stress and inhibit neurotoxicity in vitro and in vivo through catalase‐like activity and metabolic regulation. Adv Sci. 2018;5:1700595.10.1002/advs.201700595 ↗
46. Li K, Chen J, Bai S, Wen X, Song S, Yu Q, et al. Intracellular oxidative stress and cadmium ions release induce cytotoxicity of unmodified cadmium sulfide quantum dots. Toxicol Vitro. 2009;23:1007–13.10.1016/j.tiv.2009.06.020 ↗
47. Gagné F, Auclair J, Turcotte P, Fournier M, Gagnon C, Sauvé S, et al. Ecotoxicity of CdTe quantum dots to freshwater mussels: impacts on immune system, oxidative stress and genotoxicity. Aquat Toxicol. 2008;86:333–40.10.1016/j.aquatox.2007.11.013 ↗
48. Luo W, Wang Y, Lin F, Liu Y, Gu R, Liu W, et al. Selenium-doped carbon quantum dots efficiently ameliorate secondary spinal cord injury via scavenging reactive oxygen species. Int J Nanomed. 2020;15:10113–25.10.2147/IJN.S282985 ↗
49. Fang Q, Tang M. Oxidative stress-induced neurotoxicity of quantum dots and influencing factors. Nanomedicine. 2024;19:1013–28.10.2217/nnm-2023-0326 ↗
50. Wu T, Liang X, Liu X, Li Y, Wang Y, Kong L, et al. Induction of ferroptosis in response to graphene quantum dots through mitochondrial oxidative stress in microglia. Part Fibre Toxicol. 2020;17:30.10.1186/s12989-020-00363-1 ↗
51. Guo X, Lie Q, Liu Y, Jia Z, Gong Y, Yuan X, et al. Multifunctional selenium quantum dots for the treatment of Alzheimer’s disease by reducing Aβ-neurotoxicity and oxidative stress and alleviate neuroinflammation. ACS Appl Mater Interfaces. 2021;13:30261–73.10.1021/acsami.1c00690 ↗
52. Yadav P, Mimansa, Kailasam K, Shanavas A. Nontoxic metal-free visible light-responsive carbon nitride quantum dots cause oxidative stress and cancer-specific membrane damage. ACS Appl Bio Mater. 2022;5:1169–78.10.1021/acsabm.1c01219 ↗
53. Gill SS, Ponniah HS, Giersztein S, Anantharaj RM, Namireddy SR, Killilea J, et al. The diagnostic and prognostic capability of artificial intelligence in spinal cord injury: a systematic review. Brain Spine. 2025;5:104208.10.1016/j.bas.2025.104208 ↗
54. Tao G, Yang S, Xu J, Wang L, Yang B. Global research trends and hotspots of artificial intelligence research in spinal cord neural injury and restoration – a bibliometrics and visualization analysis. Front Neurol. 2024;15:1361235.10.3389/fneur.2024.1361235 ↗
55. Dietz N, Jaganathan V, Alkin V, Mettille J, Boakye M, Drazin D. Machine learning in clinical diagnosis, prognostication, and management of acute traumatic spinal cord injury (SCI): A systematic review. J Clin Orthop Trauma. 2022;35:102046.10.1016/j.jcot.2022.102046 ↗
56. Arslan YZ, Demirer RM, Palamar D, Ugur M, Karamehmetoglu SS. Comparison of the data classification approaches to diagnose spinal cord injury. Comput Math Methods Med. 2012;2012:803980.10.1155/2012/803980 ↗
57. Tay B, Hyun JK, Oh S. A machine learning approach for specification of spinal cord injuries using fractional anisotropy values obtained from diffusion tensor images. Comput Math Methods Med. 2014;2014:276589.10.1155/2014/276589 ↗
58. Zhou J, Yang Y, Zhang CY. Toward biocompatible semiconductor quantum dots: from biosynthesis and bioconjugation to biomedical application. Chem Rev. 2015;115:11669–717.10.1021/acs.chemrev.5b00049 ↗
59. Wang L, Wang Y, Xu T, Liao H, Yao C, Liu Y, et al. Gram-scale synthesis of single-crystalline graphene quantum dots with superior optical properties. Nat Commun. 2014;5:5357.10.1038/ncomms6357 ↗
60. Resch-Genger U, Grabolle M, Cavaliere-Jaricot S, Nitschke R, Nann T. Quantum dots versus organic dyes as fluorescent labels. Nat Methods. 2008;5:763–75.10.1038/nmeth.1248 ↗
61. Schmidt R, Krasselt C, Göhler C, von Borczyskowski C. The fluorescence intermittency for quantum dots is not power-law distributed: a luminescence intensity resolved approach. Acs Nano. 2014;8:3506–21.10.1021/nn406562a ↗
62. Wagner AM, Knipe JM, Orive G, Peppas NA. Quantum dots in biomedical applications. Acta Biomater. 2019;94:44–63.10.1016/j.actbio.2019.05.022 ↗
63. Oh E, Liu R, Nel A, Gemill KB, Bilal M, Cohen Y, et al. Meta-analysis of cellular toxicity for cadmium-containing quantum dots. Nat Nanotechnol. 2016;11:479–86.10.1038/nnano.2015.338 ↗
64. Sikiru S, Oladosu TL, Kolawole SY, Mubarak LA, Soleimani H, Afolabi LO, et al. Advance and prospect of carbon quantum dots synthesis for energy conversion and storage application: A comprehensive review. J Energy Storage. 2023;60:106556.10.1016/j.est.2022.106556 ↗
65. Das P, Ganguly S, Banerjee S, Das NC. Graphene based emergent nanolights: A short review on the synthesis, properties and application. Res Chem Intermed. 2019;45:3823–53.10.1007/s11164-019-03823-2 ↗
66. Valizadeh A, Mikaeili H, Samiei M, Farkhani SM, Zarghami N, Kouhi M, et al. Quantum dots: synthesis, bioapplications, and toxicity. Nanoscale Res Lett. 2012;7:1–14.10.1186/1556-276X-7-480 ↗
67. Das P, Ganguly S, Agarwal T, Maity P, Ghosh S, Choudhary S, et al. Heteroatom doped blue luminescent carbon dots as a nano-probe for targeted cell labeling and anticancer drug delivery vehicle. Mater Chem Phys. 2019;237:121860.10.1016/j.matchemphys.2019.121860 ↗
68. Das P, Ganguly S, Margel S, Gedanken A. Immobilization of heteroatom-doped carbon dots onto nonpolar plastics for antifogging, antioxidant, and food monitoring applications. Langmuir. 2021;37:3508–20.10.1021/acs.langmuir.1c00471 ↗
69. Wang W, Li Y, Cheng L, Cao Z, Liu W. Water-soluble and phosphorus-containing carbon dots with strong green fluorescence for cell labeling. J Mater Chem B. 2014;2:46–8.10.1039/C3TB21370F ↗
70. Biranje A, Azmi N, Tiwari A, Chaskar A. Quantum dots based fluorescent probe for the selective detection of heavy metal ions. J Fluoresc. 2021;31:1241–50.10.1007/s10895-021-02755-8 ↗
71. Ganguly S, Das P, Das S, Ghorai U, Bose M, Ghosh S, et al. Microwave assisted green synthesis of Zwitterionic photolumenescent N-doped carbon dots: An efficient ‘on-off’chemosensor for tracer Cr (+6) considering the inner filter effect and nano drug-delivery vector. Colloids Surf A: Physicochem Eng Asp. 2019;579:123604.10.1016/j.colsurfa.2019.123604 ↗
72. Tabish M, Malik I, Alshahrani AM, Afzal M. Detection of an oxidative stress metabolite associated with neurodegenerative diseases: effect of heteroatom doped antioxidant carbon dots. RSC Adv. 2025;15:8354–66.10.1039/D5RA00274E ↗
73. Fahad Halim A, Poinern GEJ, Fawcett D, Sharma R, Surendran S. Biomass‐derived carbon nanomaterials: synthesis and applications in textile wastewater treatment, sensors, energy storage, and conversion technologies. CleanMat. 2024;2:4–58.10.1002/clem.15 ↗
74. Dhoble SJ, Nande A, Kalyani NT, Tiwari A, Arof AK. Functional materials from carbon, inorganic, and organic sources: Methods and advances. United States: Woodhead Publishing; 2022.
75. Ganguly S, Das P, Itzhaki E, Hadad E, Gedanken A, Margel S. Microwave-synthesized polysaccharide-derived carbon dots as therapeutic cargoes and toughening agents for elastomeric gels. ACS Appl Mater Interfaces. 2020;12:51940–51.10.1021/acsami.0c14527 ↗
76. Ganguly S, Margel S. Fluorescent quantum dots-based hydrogels: Synthesis, fabrication and multimodal biosensing. Talanta Open. 2023;8:100243.10.1016/j.talo.2023.100243 ↗
77. Tian P, Tang L, Teng K, Lau S. Graphene quantum dots from chemistry to applications. Mater Today Chem. 2018;10:221–58.10.1016/j.mtchem.2018.09.007 ↗
78. Bacon M, Bradley SJ, Nann T. Graphene quantum dots. Part Part Syst Charact. 2014;31:415–28.10.1002/ppsc.201300252 ↗
79. Lu ZJ, Hu WJ, Qi XD, Sun DX, Wang Y, Yang JH. Selective localization of carbonized polymer dots in amorphous phase towards high breakdown strength and energy density of PVDF-based dielectric composites. Compos Part B: Eng. 2024;283:111627.10.1016/j.compositesb.2024.111627 ↗
80. Wang B, Waterhouse GI, Yang B, Lu S. Advances in shell and core engineering of carbonized polymer dots for enhanced applications. Acc Chem Res. 2024;57:2928–39.10.1021/acs.accounts.4c00516 ↗
81. Luppi BT, Primrose WL, Hudson ZM. Polymer dots with delayed fluorescence and tunable cellular uptake for photodynamic therapy and time‐gated imaging. Angew Chem Int Ed. 2024;63:e202400712.10.1002/anie.202400712 ↗
82. Wang F, Zhou S, Zhang Y, Wang Y, Guo R, Xiao H, et al. Chiral phosphorescent carbonized polymer dots relayed light‐harvesting system for color‐tunable circularly polarized room temperature phosphorescence. Small. 2024;20:2306969.10.1002/smll.202306969 ↗
83. Karami MH, Abdouss M. Recent advances of carbon quantum dots in tumor imaging. Nanomed J. 2024;11:13–35.
84. Gulati S, Baul A, Amar A, Wadhwa R, Kumar S, Varma RS. Eco-friendly and sustainable pathways to photoluminescent carbon quantum dots (CQDs). Nanomaterials. 2023;13:554.10.3390/nano13030554 ↗
85. Kortel M, Mansuriya BD, Vargas Santana N, Altintas Z. Graphene quantum dots as flourishing nanomaterials for bio-imaging, therapy development, and micro-supercapacitors. Micromachines. 2020;11:866.10.3390/mi11090866 ↗
86. Zhu Y-J, Chen F. Microwave-assisted preparation of inorganic nanostructures in liquid phase. Chem Rev. 2014;114:6462–555.10.1021/cr400366s ↗
87. Ahmed SF, Mofijur M, Rafa N, Chowdhury AT, Chowdhury S, Nahrin M, et al. Green approaches in synthesising nanomaterials for environmental nanobioremediation: Technological advancements, applications, benefits and challenges. Environ Res. 2022;204:111967.10.1016/j.envres.2021.111967 ↗
88. Zhang Y, Clapp A. Overview of stabilizing ligands for biocompatible quantum dot nanocrystals. Sensors. 2011;11:11036–55.10.3390/s111211036 ↗
89. Karakoti AS, Shukla R, Shanker R, Singh S. Surface functionalization of quantum dots for biological applications. Adv Colloid Interface Sci. 2015;215:28–45.10.1016/j.cis.2014.11.004 ↗
90. Wenger WN, Bates FS, Aydil ES. Functionalization of cadmium selenide quantum dots with poly (ethylene glycol): ligand exchange, surface coverage, and dispersion stability. Langmuir. 2017;33:8239–45.10.1021/acs.langmuir.7b01924 ↗
91. Mansur HS. Quantum dots and nanocomposites. Wiley Interdiscip Reviews: Nanomed Nanobiotechnol. 2010;2:113–29.10.1002/wnan.78 ↗
92. Wang W, Zhang M, Pan Z, Biesold GM, Liang S, Rao H, et al. Colloidal inorganic ligand-capped nanocrystals: fundamentals, status, and insights into advanced functional nanodevices. Chem Rev. 2021;122:4091–162.10.1021/acs.chemrev.1c00478 ↗
93. Wang F, Tan WB, Zhang Y, Fan X, Wang M. Luminescent nanomaterials for biological labelling. Nanotechnology. 2005;17:R1.10.1088/0957-4484/17/1/R01 ↗
94. Chan WC, Maxwell DJ, Gao X, Bailey RE, Han M, Nie S. Luminescent quantum dots for multiplexed biological detection and imaging. Opin Biotechnol. 2002;13:40–6.10.1016/S0958-1669(02)00282-3 ↗
95. Gao X, Nie S. Quantum dot-encoded mesoporous beads with high brightness and uniformity: rapid readout using flow cytometry. Anal Chem. 2004;76:2406–10.10.1021/ac0354600 ↗
96. Wu X, Liu H, Liu J, Haley KN, Treadway JA, Larson JP, et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol. 2003;21:41–6.10.1038/nbt764 ↗
97. Chan WC, Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science. 1998;281:2016–8.10.1126/science.281.5385.2016 ↗
98. Panchuk-Voloshina N, Haugland RP, Bishop-Stewart J, Bhalgat MK, Millard PJ, Mao F, et al. Alexa dyes, a series of new fluorescent dyes that yield exceptionally bright, photostable conjugates. J Histochem Cytochem. 1999;47:1179–88.10.1177/002215549904700910 ↗
99. Liu C, Zhang P, Zhai X, Tian F, Li W, Yang J, et al. Nano-carrier for gene delivery and bioimaging based on carbon dots with PEI-passivation enhanced fluorescence. Biomaterials. 2012;33:3604–13.10.1016/j.biomaterials.2012.01.052 ↗
100. Dong Y, Pang H, Yang HB, Guo C, Shao J, Chi Y, et al. Carbon-based dots co-doped with nitrogen and sulfur for high quantum yield and excitation-independent emission. Angew Chem Int Ed. 2013;52:7800–4.10.1002/anie.201301114 ↗